About our focus—Aytu is different

Aytu is not a traditional research company. By acquiring or licensing approved, commercialized products and late-stage development therapeutics, we bring novel and needed treatments to market and to the millions of patients that need them. Novel products that can really help people feel better—and these products can make an impact today on patients’ health and well-being.

Improving virility, suppressing severe cough and delivering better sleep

Aytu is unique in our outlook toward the products we stand behind. And we are advancing unique therapeutics and diagnostics to improve and enhance vitality, reproductive health, severe cough and insomnia.

Aytu products at a glance

NATESTO® (testosterone) nasal gel, the only FDA-approved nasally administered testosterone indicated for replacement therapy in adult males with a deficiency or absence of endogenous testosterone due to primary hypogonadism.

TUZISTRA® XR (Codiene Polistirex and Chlorpheniramine Polistirex) is the only codeine-based extended-release oral suspension cough-cold treatment in the US prescription cough-cold market.

ZOLPIMIST™ (zolpidem tartrate) Oral Spray, the only FDA-approved oral spray zolpidem product indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.

THE MiOXSYS® SYSTEM  A novel, rapid in vitro diagnostic semen analysis system with the potential to become a standard of care in the diagnosis and management of male infertility.